Lai Kai Pharmaceuticals-B (02105.HK) issued a total of 2.73 million ordinary shares under the 2024 stock incentive plan.

The Wise Finance APP News informs that Lai Kai Medicine-B (02105.HK) has announced that the company issued a total of 2.73 million ordinary shares on September 5, 2025 to meet the attribution of RSUs granted under the 2024 stock incentive plan.